• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. LXC12; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. LXC12; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXC12
Device Problems Material Erosion (1214); Malposition of Device (2616)
Patient Problems Pocket Erosion (2013); No Code Available (3191)
Event Date 04/23/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.The dhr for lot 3878 was reviewed.No ncs, defects, or reworks were found.
 
Event Description
It was reported, linx removed due to erosion.The patient did not have an autoimmune disease.Medication taken, lansoprazole 2 weeks.The implant date is unknown.There were no intra-op complications.There was no hiatal hernia/crural done at the time of implant.The device was not found at the correct position/geometry at the time of removal (erosion).A new linx was not place after the initial linx was removed.Thee beads eroded.The patient stayed 2 days and then was discharged.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).Date sent: 07/17/2019.Additional information was requested, and the following was obtained: what was the date of implant? what were the first clinical symptoms that provided evidence of an erosion and when did they first occur? has the patient had any dilations, egd, or other procedure between the linx implant and discovery of the erosion? please describe and include the dates of the procedures.Where were the eroded beads positioned? was the patient stented? response: there is no additional information for this complaint.
 
Manufacturer Narrative
(b)(4).Date sent:09/04/2019.Device analysis: overall review of the device function and dimensions show no anomalies from a device that has been reasonably changed as part of the explant procedure.Visual analysis was consistent with an explanted device, and link length and tensile force were found to meet the applicable specifications.Overall, no analysis conclusions relevant to the patient experience were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LXC12
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key8617275
MDR Text Key145294972
Report Number3008766073-2019-00351
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005134
UDI-Public00855106005134
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup,Followup,Followup
Report Date 05/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/17/2016
Device Catalogue NumberLXC12
Device Lot Number3878
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer05/31/2019
Initial Date Manufacturer Received 05/02/2019
Initial Date FDA Received05/16/2019
Supplement Dates Manufacturer Received05/31/2019
06/26/2019
08/20/2019
Supplement Dates FDA Received06/18/2019
07/17/2019
09/04/2019
Patient Sequence Number1
-
-